

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.06466485 |
| 2 | positive thymic T cell selection (GO:0045059) | 4.39078677 |
| 3 | cellular extravasation (GO:0045123) | 4.26839637 |
| 4 | immunoglobulin mediated immune response (GO:0016064) | 4.23449724 |
| 5 | iron-sulfur cluster assembly (GO:0016226) | 4.12782465 |
| 6 | metallo-sulfur cluster assembly (GO:0031163) | 4.12782465 |
| 7 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.10594423 |
| 8 | positive regulation of prostaglandin secretion (GO:0032308) | 4.09666556 |
| 9 | sleep (GO:0030431) | 4.09638629 |
| 10 | negative thymic T cell selection (GO:0045060) | 4.01482151 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00198755 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.00198755 |
| 13 | DNA deamination (GO:0045006) | 3.93471111 |
| 14 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.92685084 |
| 15 | microglial cell activation (GO:0001774) | 3.88228178 |
| 16 | negative T cell selection (GO:0043383) | 3.86499148 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.80379690 |
| 18 | positive regulation of heat generation (GO:0031652) | 3.78665230 |
| 19 | adult feeding behavior (GO:0008343) | 3.76965053 |
| 20 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.68783991 |
| 21 | positive regulation of mast cell degranulation (GO:0043306) | 3.68783991 |
| 22 | positive regulation of mast cell activation (GO:0033005) | 3.68612438 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64668120 |
| 24 | leukocyte degranulation (GO:0043299) | 3.63019211 |
| 25 | mast cell activation (GO:0045576) | 3.54272667 |
| 26 | retinal cone cell development (GO:0046549) | 3.53096607 |
| 27 | mast cell activation involved in immune response (GO:0002279) | 3.51997901 |
| 28 | mast cell degranulation (GO:0043303) | 3.51997901 |
| 29 | natural killer cell activation involved in immune response (GO:0002323) | 3.51535921 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.50493605 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.48285556 |
| 32 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.48162547 |
| 33 | respiratory burst (GO:0045730) | 3.45489574 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.38401896 |
| 35 | regulation of prostaglandin secretion (GO:0032306) | 3.37022304 |
| 36 | positive T cell selection (GO:0043368) | 3.36902476 |
| 37 | regulation of fever generation (GO:0031620) | 3.36371075 |
| 38 | regulation of mast cell activation (GO:0033003) | 3.34870297 |
| 39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29365425 |
| 40 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.28958789 |
| 41 | lymph node development (GO:0048535) | 3.27552516 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.25126692 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24797884 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24284235 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22101199 |
| 46 | negative regulation of B cell proliferation (GO:0030889) | 3.20218063 |
| 47 | neutrophil activation (GO:0042119) | 3.19377773 |
| 48 | T cell migration (GO:0072678) | 3.17986718 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.15514892 |
| 50 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.13838249 |
| 51 | B cell mediated immunity (GO:0019724) | 3.08015463 |
| 52 | defense response to protozoan (GO:0042832) | 3.07745061 |
| 53 | lymphocyte chemotaxis (GO:0048247) | 3.07618496 |
| 54 | response to interleukin-15 (GO:0070672) | 3.03200650 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01328952 |
| 56 | sequestering of actin monomers (GO:0042989) | 2.97483363 |
| 57 | thrombin receptor signaling pathway (GO:0070493) | 2.97113596 |
| 58 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.96889017 |
| 59 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96099396 |
| 60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91924539 |
| 61 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.91745773 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91569225 |
| 63 | protein neddylation (GO:0045116) | 2.87142248 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85849943 |
| 65 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.84846506 |
| 66 | T cell receptor signaling pathway (GO:0050852) | 2.82660684 |
| 67 | tolerance induction (GO:0002507) | 2.82344628 |
| 68 | granulocyte activation (GO:0036230) | 2.81156994 |
| 69 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.80091445 |
| 70 | killing of cells of other organism (GO:0031640) | 2.79736969 |
| 71 | disruption of cells of other organism (GO:0044364) | 2.79736969 |
| 72 | neutrophil mediated immunity (GO:0002446) | 2.79508932 |
| 73 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.77759367 |
| 74 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.76483784 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76095945 |
| 76 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76095945 |
| 77 | adenosine metabolic process (GO:0046085) | 2.75983658 |
| 78 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74293969 |
| 79 | regulation of heat generation (GO:0031650) | 2.74132671 |
| 80 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.73434363 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.72829690 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 2.72829690 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 2.72829690 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 2.72829690 |
| 85 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.72829690 |
| 86 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.72829690 |
| 87 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72708752 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 2.72194591 |
| 89 | positive regulation of fatty acid transport (GO:2000193) | 2.71598543 |
| 90 | T cell costimulation (GO:0031295) | 2.71256082 |
| 91 | regulation of interleukin-8 secretion (GO:2000482) | 2.71156044 |
| 92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70221367 |
| 93 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.70038850 |
| 94 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.70004993 |
| 95 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.69260057 |
| 96 | lymphocyte costimulation (GO:0031294) | 2.67713682 |
| 97 | macrophage activation (GO:0042116) | 2.67642800 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.67188911 |
| 99 | positive regulation of icosanoid secretion (GO:0032305) | 2.66212876 |
| 100 | regulation of B cell proliferation (GO:0030888) | 2.64639100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.50342417 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.37272096 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.12402074 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.01075800 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.83132986 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21767660 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.09286500 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.05479074 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83976831 |
| 10 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.76892744 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36711171 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.32869031 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.29319571 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26350746 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.25364472 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16308695 |
| 17 | GATA3_26560356_Chip-Seq_TH2_Human | 2.08683371 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08004956 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02879495 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99806883 |
| 21 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.90469966 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88032554 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78428225 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75924360 |
| 25 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.73580823 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72453999 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63974755 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.58519408 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54745422 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53645986 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50600763 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50298428 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.45705041 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45098089 |
| 35 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.43105007 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.39220199 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38887786 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38727468 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38436582 |
| 40 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36967640 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36250961 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.36236021 |
| 43 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33576038 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.32885776 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32628625 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32416861 |
| 47 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30976791 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29565215 |
| 49 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.29002650 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24518782 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22399144 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21975448 |
| 53 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21470743 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20719835 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19745883 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18911087 |
| 57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18911087 |
| 58 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16681471 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16437390 |
| 60 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16359162 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16155230 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13122019 |
| 63 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10033483 |
| 64 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10033483 |
| 65 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08857799 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08685137 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06985473 |
| 68 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05426325 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05281259 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05038330 |
| 71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04959472 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04881047 |
| 73 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03839899 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03696569 |
| 75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03662984 |
| 76 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.03612113 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03575216 |
| 78 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01386117 |
| 79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01125342 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00681624 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98271830 |
| 82 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97121527 |
| 83 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96869412 |
| 84 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.96655329 |
| 85 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95248317 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95096662 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95042742 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93231927 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93099384 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92696568 |
| 91 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.91827884 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90963814 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90796918 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88646937 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.86916071 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.86419226 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86100446 |
| 98 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86003003 |
| 99 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.85242720 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84958730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.81946586 |
| 2 | MP0003724_increased_susceptibility_to | 3.84394005 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.49787341 |
| 4 | MP0005671_abnormal_response_to | 3.43123752 |
| 5 | MP0000685_abnormal_immune_system | 2.83456607 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 2.73389993 |
| 7 | MP0001800_abnormal_humoral_immune | 2.70399230 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 2.61024499 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.57153622 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.55175534 |
| 11 | MP0003436_decreased_susceptibility_to | 2.55118723 |
| 12 | MP0003195_calcinosis | 2.51957712 |
| 13 | MP0002723_abnormal_immune_serum | 2.33509891 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.28287876 |
| 15 | MP0001819_abnormal_immune_cell | 2.25549271 |
| 16 | MP0009785_altered_susceptibility_to | 2.22416889 |
| 17 | MP0006082_CNS_inflammation | 2.19727796 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.17552216 |
| 19 | MP0002419_abnormal_innate_immunity | 2.15975796 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.08244001 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.05152721 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.02825260 |
| 23 | MP0001790_abnormal_immune_system | 1.96435962 |
| 24 | MP0005387_immune_system_phenotype | 1.96435962 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 1.95328718 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.92746330 |
| 27 | MP0005025_abnormal_response_to | 1.86292392 |
| 28 | MP0009764_decreased_sensitivity_to | 1.84889301 |
| 29 | MP0003283_abnormal_digestive_organ | 1.80531553 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.78428792 |
| 31 | MP0002405_respiratory_system_inflammati | 1.69109770 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.69076342 |
| 33 | MP0000716_abnormal_immune_system | 1.68786167 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.68773423 |
| 35 | MP0002102_abnormal_ear_morphology | 1.67435170 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.60524121 |
| 37 | MP0002398_abnormal_bone_marrow | 1.59629254 |
| 38 | MP0005171_absent_coat_pigmentation | 1.59624883 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.58161925 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.55967599 |
| 41 | MP0003866_abnormal_defecation | 1.51840671 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.49404441 |
| 43 | MP0003878_abnormal_ear_physiology | 1.49146336 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.49146336 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.49099942 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.44531377 |
| 47 | MP0002722_abnormal_immune_system | 1.41161241 |
| 48 | MP0003787_abnormal_imprinting | 1.39619648 |
| 49 | MP0004043_abnormal_pH_regulation | 1.38858784 |
| 50 | MP0000566_synostosis | 1.33136524 |
| 51 | MP0002933_joint_inflammation | 1.32065475 |
| 52 | MP0001853_heart_inflammation | 1.31416093 |
| 53 | MP0002429_abnormal_blood_cell | 1.29263940 |
| 54 | MP0004510_myositis | 1.26356008 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.25436308 |
| 56 | MP0002006_tumorigenesis | 1.20497233 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.20443582 |
| 58 | MP0003303_peritoneal_inflammation | 1.16455295 |
| 59 | MP0002009_preneoplasia | 1.08544381 |
| 60 | MP0001529_abnormal_vocalization | 1.07331102 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.06220770 |
| 62 | MP0004885_abnormal_endolymph | 1.03240418 |
| 63 | MP0003646_muscle_fatigue | 0.99478917 |
| 64 | MP0002822_catalepsy | 0.98327498 |
| 65 | MP0003252_abnormal_bile_duct | 0.97613985 |
| 66 | MP0001851_eye_inflammation | 0.96954648 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 0.95011778 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.90624009 |
| 69 | MP0004883_abnormal_blood_vessel | 0.90203091 |
| 70 | MP0004484_altered_response_of | 0.87450941 |
| 71 | MP0010155_abnormal_intestine_physiology | 0.85743996 |
| 72 | MP0003075_altered_response_to | 0.84607945 |
| 73 | MP0001663_abnormal_digestive_system | 0.83313470 |
| 74 | MP0006054_spinal_hemorrhage | 0.79860090 |
| 75 | MP0008469_abnormal_protein_level | 0.79677993 |
| 76 | MP0004947_skin_inflammation | 0.76208675 |
| 77 | MP0006276_abnormal_autonomic_nervous | 0.76049099 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.74585683 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.74034549 |
| 80 | MP0001324_abnormal_eye_pigmentation | 0.73823234 |
| 81 | MP0005390_skeleton_phenotype | 0.72682989 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.72480464 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.72101123 |
| 84 | MP0004381_abnormal_hair_follicle | 0.71424812 |
| 85 | MP0008057_abnormal_DNA_replication | 0.70993969 |
| 86 | MP0001873_stomach_inflammation | 0.70818399 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.69872856 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.69340756 |
| 89 | MP0003828_pulmonary_edema | 0.65855124 |
| 90 | MP0002132_abnormal_respiratory_system | 0.65249477 |
| 91 | MP0003186_abnormal_redox_activity | 0.64881063 |
| 92 | MP0003011_delayed_dark_adaptation | 0.63930690 |
| 93 | MP0001293_anophthalmia | 0.62946284 |
| 94 | MP0002938_white_spotting | 0.61460915 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.60754889 |
| 96 | MP0005310_abnormal_salivary_gland | 0.60060065 |
| 97 | MP0002928_abnormal_bile_duct | 0.59078321 |
| 98 | MP0002234_abnormal_pharynx_morphology | 0.58856174 |
| 99 | MP0005253_abnormal_eye_physiology | 0.58586869 |
| 100 | MP0005166_decreased_susceptibility_to | 0.58009173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal infarctions (HP:0005244) | 5.01128069 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 4.14010548 |
| 3 | Obstructive lung disease (HP:0006536) | 4.14010548 |
| 4 | Hemoptysis (HP:0002105) | 3.98822488 |
| 5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.79726108 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 3.79726108 |
| 7 | Abnormality of the prostate (HP:0008775) | 3.79511549 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75921769 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75921769 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.73316249 |
| 11 | Myositis (HP:0100614) | 3.68425812 |
| 12 | T lymphocytopenia (HP:0005403) | 3.57772664 |
| 13 | Vasculitis (HP:0002633) | 3.46315059 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.44692679 |
| 15 | Optic neuritis (HP:0100653) | 3.44692679 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.42551758 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.32443184 |
| 18 | Orchitis (HP:0100796) | 3.31498392 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29755729 |
| 20 | Constricted visual fields (HP:0001133) | 3.23811722 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.23749205 |
| 22 | Stomatitis (HP:0010280) | 3.20791082 |
| 23 | Meningitis (HP:0001287) | 3.20117393 |
| 24 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.01572887 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 2.94630655 |
| 26 | Absent thumb (HP:0009777) | 2.89434132 |
| 27 | Abnormality of T cells (HP:0002843) | 2.89018436 |
| 28 | Stomach cancer (HP:0012126) | 2.87098144 |
| 29 | Glomerulopathy (HP:0100820) | 2.84008495 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 2.80671780 |
| 31 | Hypomagnesemia (HP:0002917) | 2.80107120 |
| 32 | Gangrene (HP:0100758) | 2.77866784 |
| 33 | Recurrent bronchitis (HP:0002837) | 2.77648318 |
| 34 | Peritonitis (HP:0002586) | 2.76764611 |
| 35 | Recurrent skin infections (HP:0001581) | 2.71929191 |
| 36 | Chest pain (HP:0100749) | 2.70544745 |
| 37 | Abnormality of the pleura (HP:0002103) | 2.67300648 |
| 38 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.64166975 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.60180006 |
| 40 | Abnormality of iron homeostasis (HP:0011031) | 2.59020178 |
| 41 | Hypothermia (HP:0002045) | 2.56852245 |
| 42 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.56801784 |
| 43 | Prostate neoplasm (HP:0100787) | 2.53275626 |
| 44 | IgG deficiency (HP:0004315) | 2.50879492 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.50452248 |
| 46 | Anorexia (HP:0002039) | 2.46684269 |
| 47 | Periorbital edema (HP:0100539) | 2.46225252 |
| 48 | Pancytopenia (HP:0001876) | 2.44419777 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.43654513 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.43311315 |
| 51 | Pulmonary embolism (HP:0002204) | 2.42996833 |
| 52 | Encephalitis (HP:0002383) | 2.41914167 |
| 53 | Arterial thrombosis (HP:0004420) | 2.40708847 |
| 54 | Facial edema (HP:0000282) | 2.35798401 |
| 55 | Ureteral obstruction (HP:0006000) | 2.35509710 |
| 56 | Polyneuropathy (HP:0001271) | 2.28886118 |
| 57 | Reticulocytopenia (HP:0001896) | 2.25712323 |
| 58 | Pulmonary fibrosis (HP:0002206) | 2.23207379 |
| 59 | Hypoplastic nipples (HP:0002557) | 2.21658654 |
| 60 | Leukocytosis (HP:0001974) | 2.17818479 |
| 61 | Abnormality of male internal genitalia (HP:0000022) | 2.16401586 |
| 62 | Pustule (HP:0200039) | 2.16053878 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.14305739 |
| 64 | Carpal bone hypoplasia (HP:0001498) | 2.09920161 |
| 65 | Birth length less than 3rd percentile (HP:0003561) | 2.09881935 |
| 66 | Limb hypertonia (HP:0002509) | 2.08947409 |
| 67 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08909203 |
| 68 | Recurrent viral infections (HP:0004429) | 2.08648546 |
| 69 | Abnormality of the pericardium (HP:0001697) | 2.08550068 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.08420872 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.07662474 |
| 72 | Papilledema (HP:0001085) | 2.07006430 |
| 73 | Abnormal ciliary motility (HP:0012262) | 2.03313506 |
| 74 | Diplopia (HP:0000651) | 2.02191132 |
| 75 | Abnormality of binocular vision (HP:0011514) | 2.02191132 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.02040625 |
| 77 | Urticaria (HP:0001025) | 2.00429998 |
| 78 | Ureteral stenosis (HP:0000071) | 1.97540115 |
| 79 | Bronchitis (HP:0012387) | 1.95913572 |
| 80 | Tetany (HP:0001281) | 1.95075472 |
| 81 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.93086645 |
| 82 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.93086645 |
| 83 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.92943735 |
| 84 | Long clavicles (HP:0000890) | 1.92929509 |
| 85 | Joint swelling (HP:0001386) | 1.92816781 |
| 86 | Skin rash (HP:0000988) | 1.84458611 |
| 87 | Septo-optic dysplasia (HP:0100842) | 1.82701405 |
| 88 | Recurrent sinusitis (HP:0011108) | 1.82247760 |
| 89 | Restrictive lung disease (HP:0002091) | 1.82019741 |
| 90 | Cerebral palsy (HP:0100021) | 1.81499240 |
| 91 | Vertigo (HP:0002321) | 1.80822721 |
| 92 | Abnormality of macrophages (HP:0004311) | 1.80387068 |
| 93 | Duplicated collecting system (HP:0000081) | 1.79130610 |
| 94 | Amaurosis fugax (HP:0100576) | 1.78619993 |
| 95 | Bilateral microphthalmos (HP:0007633) | 1.77799722 |
| 96 | Chronic diarrhea (HP:0002028) | 1.77358205 |
| 97 | Abnormality of midbrain morphology (HP:0002418) | 1.76918752 |
| 98 | Molar tooth sign on MRI (HP:0002419) | 1.76918752 |
| 99 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.76638862 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 1.74833963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK6 | 4.14707943 |
| 2 | MUSK | 4.11334670 |
| 3 | ZAK | 3.53575867 |
| 4 | MAP4K1 | 3.16671919 |
| 5 | TXK | 3.16641171 |
| 6 | KIT | 3.05510364 |
| 7 | VRK2 | 2.79425315 |
| 8 | TAOK3 | 2.75844884 |
| 9 | TLK1 | 2.33301044 |
| 10 | GRK7 | 2.14697308 |
| 11 | TGFBR2 | 2.10090696 |
| 12 | IKBKE | 1.99106885 |
| 13 | BLK | 1.98321215 |
| 14 | SYK | 1.92032462 |
| 15 | JAK3 | 1.75191230 |
| 16 | MAP3K14 | 1.72977799 |
| 17 | GRK5 | 1.71746500 |
| 18 | CCNB1 | 1.65190875 |
| 19 | STK10 | 1.64605486 |
| 20 | CSK | 1.58363069 |
| 21 | RIPK4 | 1.56947558 |
| 22 | BTK | 1.56790994 |
| 23 | IRAK4 | 1.47905485 |
| 24 | MST4 | 1.46096648 |
| 25 | IKBKB | 1.45110484 |
| 26 | MOS | 1.43542284 |
| 27 | TBK1 | 1.36525034 |
| 28 | MAP3K11 | 1.31041758 |
| 29 | PASK | 1.30979355 |
| 30 | OXSR1 | 1.21176652 |
| 31 | CDK19 | 1.18583786 |
| 32 | FRK | 1.17443735 |
| 33 | TEC | 1.16277286 |
| 34 | ITK | 1.14686416 |
| 35 | FES | 1.14389986 |
| 36 | EIF2AK2 | 1.11870706 |
| 37 | STK16 | 1.10568126 |
| 38 | LRRK2 | 1.08493636 |
| 39 | VRK1 | 1.08387261 |
| 40 | ADRBK2 | 1.07082822 |
| 41 | PIK3CA | 1.06672869 |
| 42 | PINK1 | 1.05164108 |
| 43 | LYN | 1.01074097 |
| 44 | MATK | 1.00548908 |
| 45 | CAMKK2 | 0.99860207 |
| 46 | BMPR2 | 0.97464037 |
| 47 | CAMKK1 | 0.91861890 |
| 48 | IRAK2 | 0.90009475 |
| 49 | CSF1R | 0.89614430 |
| 50 | TYK2 | 0.89402781 |
| 51 | IRAK1 | 0.89262183 |
| 52 | MAP2K2 | 0.87831446 |
| 53 | ADRBK1 | 0.86595652 |
| 54 | ZAP70 | 0.86492631 |
| 55 | TAOK1 | 0.84448870 |
| 56 | PLK2 | 0.84334288 |
| 57 | JAK1 | 0.80679810 |
| 58 | MAP3K12 | 0.79825452 |
| 59 | MAP3K6 | 0.79033955 |
| 60 | PIM1 | 0.78390814 |
| 61 | KDR | 0.76114341 |
| 62 | PRKCQ | 0.75880926 |
| 63 | LCK | 0.75386931 |
| 64 | PIK3CG | 0.73898319 |
| 65 | PDK1 | 0.68983851 |
| 66 | JAK2 | 0.68390171 |
| 67 | HCK | 0.67243024 |
| 68 | ACVR1B | 0.62604708 |
| 69 | STK11 | 0.59935644 |
| 70 | MARK3 | 0.59638453 |
| 71 | NEK6 | 0.57466749 |
| 72 | TNK2 | 0.54357888 |
| 73 | GRK1 | 0.53648749 |
| 74 | MAPKAPK2 | 0.53473491 |
| 75 | ABL1 | 0.50529992 |
| 76 | MAPK7 | 0.49441108 |
| 77 | RPS6KA6 | 0.46523320 |
| 78 | ERBB2 | 0.44213705 |
| 79 | WNK3 | 0.42924367 |
| 80 | PLK3 | 0.41265400 |
| 81 | STK4 | 0.41009790 |
| 82 | EGFR | 0.39774101 |
| 83 | NUAK1 | 0.39675207 |
| 84 | MAP4K2 | 0.38837842 |
| 85 | MAP2K6 | 0.38461622 |
| 86 | CSNK1A1L | 0.38294216 |
| 87 | CHEK2 | 0.38052154 |
| 88 | CDK3 | 0.38022465 |
| 89 | PTK2B | 0.37954316 |
| 90 | MAPK15 | 0.35131332 |
| 91 | AURKA | 0.33778783 |
| 92 | PAK3 | 0.32814404 |
| 93 | MAPK13 | 0.31793619 |
| 94 | PRKCD | 0.30456257 |
| 95 | PRKCI | 0.29743192 |
| 96 | FGR | 0.28709941 |
| 97 | RPS6KC1 | 0.27633709 |
| 98 | RPS6KL1 | 0.27633709 |
| 99 | CSNK1G3 | 0.27093075 |
| 100 | DYRK2 | 0.27068681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.80451597 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.70385208 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.17695966 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.02503731 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.86943195 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.26153287 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14306473 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.05004709 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.92731866 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.81062475 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.25427392 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.21147506 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.01612279 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85806371 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52834341 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.52169388 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43920921 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42411502 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.35088866 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.34556205 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29053922 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20916766 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19454945 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18452922 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17832119 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15519515 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14872557 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13575577 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13321207 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13014135 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.12013787 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07842135 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.04999674 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03967856 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.00718136 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 0.94554388 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90048091 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88635523 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81862144 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80772583 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79751642 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79045591 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78496502 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77402343 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76807294 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72560419 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70256714 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69856936 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68865159 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66320485 |
| 51 | Spliceosome_Homo sapiens_hsa03040 | 0.56976003 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56806659 |
| 53 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.56296195 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56096573 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55737795 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53160076 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51383664 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51255337 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50861527 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.50540650 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49901435 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49362393 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.49310567 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48916307 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.48704768 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.47189476 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.46877294 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46779447 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44496494 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43239618 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.42826747 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.42413091 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41974561 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40161238 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38645892 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.34416782 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34391268 |
| 78 | Proteasome_Homo sapiens_hsa03050 | 0.30382784 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.29805891 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27044609 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.24087519 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.23693851 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23174859 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.22684240 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22666702 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21956804 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19180421 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18436109 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18332989 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.18132030 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.17009599 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.15523292 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12726732 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10373841 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.10123510 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.09616341 |
| 97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.08674903 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.08037029 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07943085 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07544631 |

